Hrt Financial LP Forward Pharma A/S Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.43 - $7.01 $64,307 - $83,019	-11,843 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.97 - $17.66 $70,702 - $209,147	11,843 New	11,843 $81,000
Q4 2020 Feb 16, 2021	SELL	$6.22 - $7.4 $83,752 - $99,641	-13,465 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$5.99 - $6.78 $80,655 - $91,292	13,465 New	13,465 $83,000

Ticker FWP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,091,180
Market Cap $18.2M
Description
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.